Desperate patients are travelling abroad for dubious stem cell therapies. Monya Baker investigates the potential damage not only to human lives but to reputable stem cell research.
This is a preview of subscription content, log in via an institution to check access.
References
Schachinger, V. et al. J. Am. Coll. Cardiol. 44, 1690–1699 (2004).
Wollert, K.C. et al. Lancet 364, 141–148 (2004).
Amado, L.C. et al. Proc. Natl. Acad. Sci. USA 102, 11474–11479 (2005).
Giebel, LB . Nat. Biotech. 23, 798–800 (2005).
Cyranoski, D. Nature 437, 810–811 (2005).
Zarembo, A. LA Times Feb 20, A1 (2005).
Barbados on top of medical science. Daily Nation November 21, (2004).
Author information
Authors and Affiliations
Related links
Related links
Related links in Nature Research
https://doi.org/10.1038/NatureBiotechnology23,807-815(01Jul2005)Feature
https://doi.org/10.1038/News@Nature435,877-878(16Jun2005)
https://doi.org/10.1038/News@Nature23,775-777(01Jul2005)
Web links
Rights and permissions
About this article
Cite this article
Baker, M. Stem cell therapy or snake oil?. Nat Biotechnol 23, 1467–1469 (2005). https://doi.org/10.1038/nbt1205-1467
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1205-1467
- Springer Nature America, Inc.
This article is cited by
-
Closing gaps, opening doors: an experimental collaboration in stem cell intervention
Molecular Biology Reports (2020)
-
The malignant niche: safe spaces for toxic stem cell marketing
npj Regenerative Medicine (2017)
-
Mesenchymal Stem Cells and Neurodegenerative Disease
Clinical Pharmacology & Therapeutics (2009)